483
Outin Futures CorpFDA 483 - Outin Futures Corp - August 12, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Outin Futures Corp., a manufacturer in Chungju, Korea, was cited for multiple significant deficiencies in its manufacturing practices for OTC drug products. The inspection revealed severe issues across training, stability studies, laboratory controls, in-process material management, equipment cleaning, and process validation, with several repeat observations indicating a systemic lack of adherence to cGMP regulations.
Open in Dashboard
ID · d5e94fad-0bfe-489f-a155-e7414633951e